Invasive Mucormycosis Involving the Laryngopharynx After Bone Marrow Transplantation

J Craniofac Surg. 2022 May 1;33(3):e300-e303. doi: 10.1097/SCS.0000000000008167. Epub 2021 Sep 17.

Abstract

Invasive larynx or pharyngeal fungal infections are rare. We report an invasive fungal laryngopharyngitis patient who complained of a persistent sore throat after an allogenic bone marrow transplant and a haploidentical stem cell transplant. An antifungal gargle was used after finding necrotic changes extending from the right soft palate to the aryepiglottic fold. Biopsy and culture suggested a fungal infection with suspicious mucormycosis. imaging showed the right oropharynx, supraglottis, and the para- pharnygeal space were involved. After initiating liposomal amphotericin В for 4 days, wide excisional debridement, and a partial pharyngectomy with an anterolateral thigh free flap including the deep fascia were performed. Amphotericin B and posaconazole were used subsequently. Pathology assessment indicated invasive mucormycosis. There was no recurrence for 9 months. Mucormycosis is a fatal opportunistic infection often seen in immunocompromised patients. Rapid detection, radical resection, and reconstruction can save the patient from a life-threatening fungal infection of the laryngopharynx.

MeSH terms

  • Antifungal Agents / therapeutic use
  • Bone Marrow Transplantation / adverse effects
  • Humans
  • Hypopharynx
  • Immunocompromised Host
  • Mucormycosis* / diagnosis
  • Mucormycosis* / drug therapy

Substances

  • Antifungal Agents